In episode 32 of The Functional Code, Dr. Addy and Dr. Jace delve into GLP-1 agonists like semaglutide and terzepatide, exploring their roles in weight loss and diabetes management. They discuss the mounting reliance on these medications, citing real-life examples and addressing societal and cultural impacts on health. The podcast also covers the historical adjustments to hypertension markers, the projected rise in obesity and diabetes by 2050, pharmaceutical influences, and strategies for utilizing GLP-1 agonists effectively. Listeners are encouraged to take a proactive role in their health, with insights into potential side effects, complementary strategies like resistance training and adequate protein intake, and the importance of building healthy habits.
Dr. Jace Nybo D.C.
Dr. Addy Knutson D.C.
Guide:
00:00 The Hunger Zombie Incident Intro
01:08 Welcome to the Functional Code
01:37 Introduction to GLP-1 and Weight Loss
03:33 The Obesity Epidemic
06:34 Pharmaceutical Influence and Misleading Practices
09:07 Childhood Obesity and Long-Term Health Risks
17:34 Traditional and Surgical Interventions for Obesity
21:06 The History of Diabetes and Weight Loss Medications
28:31 Understanding GLP-1 Mechanisms
36:11 The Impact of GLP-1 on Health
39:30 Misguided Medical Advice and Patient Preparation
40:42 The Hunger Zombie Phenomenon
41:28 Advancements in Weight Loss Medications
44:07 Long-Term Use and Side Effects
59:27 The Importance of Resistance Training and Protein Intake
01:02:44 Proper Management and Use of Weight Loss Medications
01:06:47 Future Developments and Final Thoughts
01:11:54 Conclusion and Final Remarks
Resources:
doi.org/10.1136/bmj-2023-078225
doi.org/10.1186/s12933-023-01765-z
doi.org/10.1016j.molmet.2020.101102
Instagram:
instagram.com/thefunctionalcode/
TicTock:
@thefunctionalcode
Apple Podcast:
podcasts.apple.com/us/podcast/the-functional-code-podcast/id1754585557
